EC Number |
BRENDA No. |
Title |
Journal |
Volume |
Pages |
Year |
Organism |
PubMed ID |
---|
2.7.10.1 | 761673 |
Development of potent inhibitors of receptor tyrosine kinases by ligand-based drug design and target-biased phenotypic screening |
J. Med. Chem. |
61 |
2104-2110 |
2018 |
Homo sapiens |
29466002 |
2.7.10.1 | 760677 |
Discovery and rational design of 2-aminopyrimidine-based derivatives targeting Janus kinase 2 (JAK2) and FMS-like tyrosine kinase 3 (FLT3) |
Bioorg. Chem. |
104 |
104361 |
2020 |
Homo sapiens |
33142418 |
2.7.10.1 | 760669 |
High levels of receptor tyrosine kinases in ccm3-deficient cells increase their susceptibility to tyrosine kinase inhibition |
Biomedicines |
8 |
1-16 |
2020 |
Homo sapiens |
33348877 |
2.7.10.1 | 761659 |
Mechanism of Mer receptor tyrosine kinase inhibition of glomerular endothelial cell inflammation |
J. Leukoc. Biol. |
103 |
709-717 |
2018 |
Mus musculus |
29350876 |
2.7.10.1 | 760845 |
Monitoring activities of receptor tyrosine kinases using a universal adapter in genetically encoded split TEV assays |
Cell. Mol. Life Sci. |
76 |
1185-1199 |
2019 |
Homo sapiens |
30623207 |
2.7.10.1 | 761882 |
Receptor tyrosine kinase signaling networks define sensitivity to ERBB inhibition and stratify KRAS-mutant lung cancers |
Mol. Cancer Ther. |
18 |
1863-1874 |
2019 |
Homo sapiens |
31320402 |
2.7.10.1 | 760838 |
RET functions as a dual-specificity kinase that requires allosteric inputs from juxtamembrane elements |
Cell Rep. |
17 |
3319-3332 |
2016 |
Homo sapiens |
28009299 |
2.7.10.1 | 762104 |
Synthesis and in vitro cytotoxicity of the 4-(halogenoanilino)-6-bromoquinazolines and their 6-(4-fluorophenyl) substituted derivatives as potential inhibitors of epidermal growth factor receptor tyrosine kinase |
Pharmaceuticals |
10 |
87 |
2017 |
Homo sapiens |
29156606 |
2.7.10.1 | 737831 |
4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase |
Bioorg. Med. Chem. Lett. |
26 |
534-539 |
2016 |
Homo sapiens |
26639762 |
2.7.10.1 | 737820 |
4-Substituted quinazoline derivatives as novel EphA2 receptor tyrosine kinase inhibitors |
Bioorg. Med. Chem. Lett. |
24 |
4080-4083 |
2014 |
Homo sapiens |
25124116 |